News, Money and Drugs for Wednesday, June 24, 2009

June 24, 2009 at 8:57 pm EST | Tags:

News, Money and Drugs for Wednesday, June 24, 2009

  • Watson Pharmaceuticals has received FDA approval to sell the first generic copy of Plan B, the emergency contraceptive made by Teva Pharmaceutical Industries. [Bloomberg]

  • Faes Farma and Pfizer? [Pharmalive]

  • FDA rejects GSK’s anti-nausea drug, Resonic (casopitant mesylate). [FierceBiotech]

  • Perfect timing! On the brink of bankruptcy, Protein Sciences gets $35M government contract for flu vaccine. [New York Times]

  • Gardasil for boys not so effective. [Bloomberg]

  • No side effects with Ista Pharmaceuticals’ Bepreve. [AP]

  • Vertex CEO speaks! [BizJournals]

  • Finally, the FTC says that eliminating patent settlements between brand-name and generic drug companies will save consumers $3.5 billion!!! What about patent lawyers???!!! Oh, they would be PO’ed for sure… [BNET Pharma]

Anonymous Tip? Comments? Contact us: hr AT iguanabio DOT com

Related Posts

| News, Money and Drugs for Wednesday, June 3, 2009 | News, Money and Drugs for Wednesday, June 10, 2009 | News, Money and Drugs for Monday, June 29, 2009 | News, Money and Drugs for Wednesday, July 8, 2009 | News, Money and Drugs for Wednesday, June 17, 2009 |


Leave a Reply

Would you like to register?